Aim of this study was the assessment of the radiation exposure from preparation and application of 90Y-Zevalin, the measurement of the dose rate at the patient, the exposure of family members as well as the determination of the activity concentration in urine of patients...
Keywords: Ibritumomab Tiuxetan, Zevalin, 90Y, ß - -Strahlung, Bremsstrahlung, Radioimmuntherapie, Strahlenexposition, Hautdosis, Strahlenschutz
01/2006 | Nuklearmedizin, Schattauer